Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. D-propoxyphene Napsylate
2. Dextropropoxyphene Napsylate
1. 17140-78-2
2. Propoxyphene Napsylate Anhydrous
3. 5o7iw35n3c
4. Darvon N
5. [(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] Propanoate;naphthalene-2-sulfonic Acid
6. Propoxyphene-n
7. (+)- Propoxyphene Napsylate
8. Propoxyphene 2-naphthalenesulfonate
9. Einecs 241-205-7
10. Unii-5o7iw35n3c
11. 2-butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, Propionate, 2-naphthalenesulfonate
12. Propoxyphene Napsylate ,(s)
13. 2-naphthalenesulfonic Acid, Compd. With (s-(r*,s*))-3-(dimethylamino)-2-methyl-1-phenyl-1-(phenylmethyl)p- Ropyl Propanoate (1:1)
14. Schembl9297768
15. Dtxsid80937986
16. Propoxyphene Napsylate, Anhydrous
17. 2-naphthalenesulfonic Acid, Compd. With (+)-alpha-(2-dimethylamino)-1-methylethyl-alpha-phenylphenethyl Propionate (1:1)
18. Benzeneethanol, Alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, Propanoate (ester), (1s,2r)-, 2-naphthalenesulfonate (salt)
19. Benzeneethanol, Alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, Propanoate (ester), (s-(r*,s*))-, 2-naphthalenesulfonate (salt)
20. Naphthalene-2-sulphonic Acid, Compound With (s-(r*,s*))-1-benzyl-3-(dimethylamino)-2-methyl-1-phenylpropyl Propionate (1:1)
21. Q27262632
22. (2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl Propionate Naphthalene-2-sulfonate
Molecular Weight | 547.7 g/mol |
---|---|
Molecular Formula | C32H37NO5S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 10 |
Exact Mass | 547.23924445 g/mol |
Monoisotopic Mass | 547.23924445 g/mol |
Topological Polar Surface Area | 92.3 Ų |
Heavy Atom Count | 39 |
Formal Charge | 0 |
Complexity | 688 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Related Excipient Companies
Excipients by Applications
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Propoxyphene Napsylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Propoxyphene Napsylate, including repackagers and relabelers. The FDA regulates Propoxyphene Napsylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Propoxyphene Napsylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Propoxyphene Napsylate supplier is an individual or a company that provides Propoxyphene Napsylate active pharmaceutical ingredient (API) or Propoxyphene Napsylate finished formulations upon request. The Propoxyphene Napsylate suppliers may include Propoxyphene Napsylate API manufacturers, exporters, distributors and traders.
click here to find a list of Propoxyphene Napsylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Propoxyphene Napsylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Propoxyphene Napsylate active pharmaceutical ingredient (API) in detail. Different forms of Propoxyphene Napsylate DMFs exist exist since differing nations have different regulations, such as Propoxyphene Napsylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Propoxyphene Napsylate DMF submitted to regulatory agencies in the US is known as a USDMF. Propoxyphene Napsylate USDMF includes data on Propoxyphene Napsylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Propoxyphene Napsylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Propoxyphene Napsylate suppliers with USDMF on PharmaCompass.
Propoxyphene Napsylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Propoxyphene Napsylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Propoxyphene Napsylate GMP manufacturer or Propoxyphene Napsylate GMP API supplier for your needs.
A Propoxyphene Napsylate CoA (Certificate of Analysis) is a formal document that attests to Propoxyphene Napsylate's compliance with Propoxyphene Napsylate specifications and serves as a tool for batch-level quality control.
Propoxyphene Napsylate CoA mostly includes findings from lab analyses of a specific batch. For each Propoxyphene Napsylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Propoxyphene Napsylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Propoxyphene Napsylate EP), Propoxyphene Napsylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Propoxyphene Napsylate USP).
LOOKING FOR A SUPPLIER?